SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950008-98-000156
Filing Date
1998-03-30
Accepted
1998-03-30 00:00:00
Documents
7
Period of Report
1997-12-31
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 INCYTE PHARMACEUTICALS, INC. FORM 10-K 10-K 217183
2 AMD AND RESTATED 1993 DIR. STOCK OPTION PLAN EX-10.4 24643
3 SUBSIDIARIES OF INCYTE PHARMACEUTICALS, INC. EX-21.1 624
4 CONSENT OF INDEPENDENT AUDITORS EX-23.1 1071
5 FDS -- ARTICLE 5 OF REGULATION S-X EX-27.1 2400
6 FDS -- ARTICLE 5 OF REGULATION S-X EX-27.1 2395
7 FDS -- ARTICLE 5 OF REGULATION S-X EX-27.1 2395
  Complete submission text file 0000950008-98-000156.txt   252887
Mailing Address 3174 PORTER DRIVE 3174 PORTER DRIVE PALO ALTO CA 94304
Business Address 3174 PORTER DR PALO ALTO CA 94304 6508550555
INCYTE PHARMACEUTICALS INC (Filer) CIK: 0000879169 (see all company filings)

IRS No.: 943136539 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-12400 | Film No.: 98578026
SIC: 8731 Services-Commercial Physical & Biological Research